Techopia

Techopia is focused on Ottawa’s technology sector. This multimedia project includes regular online news coverage, a video and audio podcast, private networking events and quarterly reports. OBJ also partners with EY to create an annual magazine called Techopia-EY Insights.

Spartan Bioscience says it’s found fix for COVID-19 test, set to reapply for Health Canada approval

Ottawa biotech firm voluntarily recalled test in May after federal regulatory agency expressed concern about its effectiveness.

Ottawa cybersecurity company Titus cuts 20% of staff following acquisition by U.S. firm

Ottawa firm that makes software that allows users to classify emails and attachments according to their level of security had about 130 employees before this week's layoffs.

Eight steps to building a stronger company amid a cash-flow crisis

Many entrepreneurs and business owners continue to grapple with persistent challenges stemming from the lingering uncertainty brought on by the pandemic.

Ottawa’s Thermal Energy inks $920K deal with European food and beverage company

Company says its system is expected to save unnamed customer more than $380,000 a year in fuel costs and reduce the site’s carbon emissions by 2,868 tonnes annually.

Ottawa software maker Amika Mobile acquired by California firm

Emergency communications software company hopes deal will help it tap into growing U.S. market.

Ottawa’s C-COM lands $1M from Canadian Space Agency

New antenna technology will be capable of tracking multiple satellites simultaneously and be more energy efficient and cheaper than current systems.

Calian Group stretches profit streak in Q3, raises 2020 revenue guidance

Kanata firm continued to rewrite its corporate record book, posting year-over-year sales gains in three of its four main service lines en route to hitting another all-time high in quarterly revenues.

Invest Ottawa, Capital Angel Network unveil first cohort of funding bootcamp for women

Eight entrepreneurs from the National Capital Region are among 10 female business founders taking part in the new program.

Ottawa biotech lab gets $56M shot in the arm for COVID vaccine research

Variation Biotechnologies is working with the National Research Council to create a vaccine that would target the novel coronavirus as well as other deadly viruses.